Hospitalization in High Fracture Risk Older Adults with Osteoporosis Using the Safe Functional Motion Test: A Longitudinal Analysis by Van Dussen, Daniel J., Recknor, Chris P., Recknor, Julie C.

Get full text

Scores on the safe functional motion test are associated with prevalent fractures and fall history by Recknor, Chris P, Grant, Stephanie L, Recknor, Julie C, Macintyre, Norma J

Get full text

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis by Cosman, Felicia, Eriksen, Erik Fink, Recknor, Chris, Miller, Paul D, Guañabens, Núria, Kasperk, Christian, Papanastasiou, Philemon, Readie, Aimee, Rao, Hanumantha, Gasser, Jürg A, Bucci‐Rechtweg, Christina, Boonen, Steven

Get full text

Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass by Genant, Harry K, Engelke, Klaus, Bolognese, Michael A, Mautalen, Carlos, Brown, Jacques P, Recknor, Chris, Goemaere, Stefan, Fuerst, Thomas, Yang, Yu‐Ching, Grauer, Andreas, Libanati, Cesar

Get full text

Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture by Eriksen, Erik Fink, Lyles, Kenneth W, Colón‐Emeric, Cathleen S, Pieper, Carl F, Magaziner, Jay S, Adachi, Jonathan D, Hyldstrup, Lars, Recknor, Chris, Nordsletten, Lars, Lavecchia, Catherine, Hu, Huilin, Boonen, Steven, Mesenbrink, Peter

Get full text

Romosozumab Enhances Vertebral Bone Structure in Women With Low Bone Density by Poole, Kenneth ES, Treece, Graham M, Pearson, Rose A, Gee, Andrew H, Bolognese, Michael A, Brown, Jacques P, Goemaere, Stefan, Grauer, Andreas, Hanley, David A, Mautalen, Carlos, Recknor, Chris, Yang, Yu‐Ching, Rojeski, Maria, Libanati, Cesar, Whitmarsh, Tristan

Get full text

Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab by Keaveny, Tony M, McClung, Michael R, Genant, Harry K, Zanchetta, Jose R, Kendler, David, Brown, Jacques P, Goemaere, Stefan, Recknor, Chris, Brandi, Maria L, Eastell, Richard, Kopperdahl, David L, Engelke, Klaus, Fuerst, Thomas, Radcliffe, Hoi‐Shen, Libanati, Cesar

Get full text

Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial by Brown, Jacques P., Chines, Arkadi, Chapurlat, Roland, Foldes, Joseph, Nogues, Xavier, Civitelli, Roberto, De Villiers, Tobias, Massari, Fabio, Zerbini, Cristiano, Yang, Wenjing, Recknor, Chris, Libanati, Cesar

Get full text

Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture by Magaziner, Jay S, Orwig, Denise L, Lyles, Kenneth W, Nordsletten, Lars, Boonen, Steven, Adachi, Jonathan D, Recknor, Chris, Colón‐Emeric, Cathleen S, Mesenbrink, Peter, Bucci‐Rechtweg, Christina, Su, Guoqin, Johnson, Rasheeda, Pieper, Carl F

Get full text

Effect of previous bisphosphonate use on response to zoledronic acid: Results from the HORIZON-PFT study by Lippuner, Kurt, Eastell, Richard, Reid, Ian, Benhamou, Claude-Laurent, Recknor, Chris, Ish-Shalom, Sophia, Bianchi, Gerolamo, Black, Dennis, Mesenbrink, Peter, Fink Eriksen, Erik, Delmas, Pierre D

Get full text